BioOrbit
OPERATING
London-based space manufacturing company developing hardware for large-scale crystallisation of protein drugs in
Founded in 2023, BioOrbit develops hardware and processes for crystallising biologic drugs—including protein antibodies—in a microgravity environment, with the aim of enabling a shift from intravenous to subcutaneous drug administration. The company operates as a CDMO serving the pharmaceutical industry and has raised approximately $13.2M in seed funding. BioOrbit is headquartered in London, UK, and has received support from ESA's Business Incubation Centre and Seraphim Space.
2023
London, United Kingdom
Private Company